Consolidated statement of changes in equity (Note 16)

x € million	Share capital	Share premium	Treasury shares	Other reserves	Retained earnings	Total	Non-controlling interests	Total Equity

Balance at 1 January 2020	338	489	(905)	96	7,713	7,731	104	7,835

Dividend	-	-	-	-	(423)	(423)	(6)	(429)
Options/performance shares granted	-	-	-	29	-	29	-	29
Options/performance shares vested/canceled	-	-	-	(39)	39	-	-	-
Reissued shares	-	-	238	-	(32)	206	-	206
Acquisition of NCI without a change in control	-	-	-	-	(22)	(22)	(10)	(32)
Acquisition (divestment) of subsidiary with NCI	-	-	-	-	-	-	(1)	(1)
Repurchase of shares	-	-	(309)	-	-	(309)	-	(309)
Transfer	-	-	-	(30)	30	-	-	-
Other	-	-	-	(3)	3	-	3	3
Total comprehensive income	-	-	-	(296)	483	187	(2)	185
Balance at 31 December 2020	338	489	(976)	(243)	7,791	7,399	88	7,487

Dividend	-	-	-	-	(421)	(421)	(3)	(424)
Options/performance shares granted	-	-	-	22	-	22	-	22
Options/performance shares vested/canceled	-	-	-	(24)	24	-	-	-
Cancellation of shares	(10)	(18)	746	-	(718)	-	-	-
Reissued shares	-	-	218	-	(25)	193	-	193
Acquisition of NCI without a change in control	-	-	-	-	(20)	(20)	7	(13)
Acquisition (divestment) of subsidiary with NCI	-	-	-	-	-	-	(24)	(24)
Repurchase of shares	-	-	(165)	-	-	(165)	-	(165)
Transfer	-	-	-	(101)	101	-	-	-
Other	-	-	-	1	(2)	(1)	(1)	(2)
Total comprehensive income	-	-	-	501	1,810	2,311	12	2,323
Balance at 31 December 2021	328	471	(177)	156	8,540	9,318	79	9,397